Walgreens Boots Alliance, Inc. (WBA) Holdings Lifted by Virtu KCG Holdings LLC

Virtu KCG Holdings LLC boosted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 22.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 47,768 shares of the pharmacy operator’s stock after buying an additional 8,599 shares during the period. Virtu KCG Holdings LLC’s holdings in Walgreens Boots Alliance were worth $3,741,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Parametric Portfolio Associates LLC increased its position in Walgreens Boots Alliance by 21.9% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 1,762,133 shares of the pharmacy operator’s stock worth $137,993,000 after buying an additional 316,745 shares during the period. WealthPLAN Partners LLC increased its position in Walgreens Boots Alliance by 3,009.3% in the 2nd quarter. WealthPLAN Partners LLC now owns 4,664 shares of the pharmacy operator’s stock worth $365,000 after buying an additional 4,514 shares during the period. Nordea Investment Management AB increased its position in Walgreens Boots Alliance by 10.2% in the 2nd quarter. Nordea Investment Management AB now owns 10,085,836 shares of the pharmacy operator’s stock worth $789,822,000 after buying an additional 931,508 shares during the period. Glenview Trust Co increased its position in Walgreens Boots Alliance by 1.4% in the 2nd quarter. Glenview Trust Co now owns 155,689 shares of the pharmacy operator’s stock worth $12,192,000 after buying an additional 2,141 shares during the period. Finally, Cibc World Markets Corp increased its position in Walgreens Boots Alliance by 76.7% in the 2nd quarter. Cibc World Markets Corp now owns 661,034 shares of the pharmacy operator’s stock worth $51,766,000 after buying an additional 286,959 shares during the period. 63.35% of the stock is currently owned by institutional investors.

A number of analysts have recently issued reports on the company. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, November 10th. Citigroup Inc. lowered their price objective on Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating on the stock in a research report on Thursday, November 2nd. Leerink Swann cut Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 1st. Zacks Investment Research upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Monday, October 30th. Finally, Jefferies Group LLC set a $93.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Sunday, October 29th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $87.63.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at $71.25 on Monday. The company has a market capitalization of $71,930.37, a PE ratio of 13.97, a P/E/G ratio of 1.27 and a beta of 1.20. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45. Walgreens Boots Alliance, Inc. has a fifty-two week low of $63.82 and a fifty-two week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.10. The business had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The firm’s revenue was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.07 earnings per share. equities analysts expect that Walgreens Boots Alliance, Inc. will post 5.55 EPS for the current fiscal year.

Walgreens Boots Alliance announced that its Board of Directors has initiated a stock repurchase program on Wednesday, October 25th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the pharmacy operator to purchase shares of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a yield of 2.25%. Walgreens Boots Alliance’s dividend payout ratio is presently 42.33%.

ILLEGAL ACTIVITY NOTICE: “Walgreens Boots Alliance, Inc. (WBA) Holdings Lifted by Virtu KCG Holdings LLC” was reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this report on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this report can be read at https://ledgergazette.com/2017/11/20/walgreens-boots-alliance-inc-wba-holdings-lifted-by-virtu-kcg-holdings-llc.html.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the sale, the director now directly owns 16,415 shares in the company, valued at $1,105,878.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director John Anthony Lederer purchased 20,000 shares of the stock in a transaction on Thursday, October 26th. The stock was acquired at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the acquisition, the director now directly owns 50,000 shares of the company’s stock, valued at $3,350,000. The disclosure for this purchase can be found here. Corporate insiders own 13.50% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply